Half a century of Dutch transplant immunology

Immunology Letters

Volumn 162, Issue 2, 2014, Pages 145-149

  van Rood, Jon J ^a   Claas, Frans H J ^a   Brand, Anneke ^a   Tilanus, Marcel G J ^b   Van Kooten, Cees ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

HLA; MHC; Transfusion; Transplantation

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN;

ALLELE; BLEEDING DISORDER; BONE MARROW TRANSPLANTATION; HISTOCOMPATIBILITY; HLA GENE; HUMAN; IMPLANT REGISTRY; KIDNEY TRANSPLANTATION; MEDICAL HISTORY; MICROCHIMERISM; NETHERLANDS; NONHUMAN; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE TRANSFUSION; ANIMAL; BLOOD TRANSFUSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTORY; ORGAN TRANSPLANTATION;

ANIMALS; BLOOD TRANSFUSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; NETHERLANDS; ORGAN TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY;

EID: 84912080761     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2014.10.017     Document Type: Review

References (46)

1. van Rood J.J., Eernisse J.G., van Leeuwen A. Leucocyte antibodies in sera from pregnant women. Nature 1958, 181(June (4625)):1735-1736.
2. van Rood J.J., van Leeuwen A. Leukocyte grouping. A method and its application. J Clin Invest 1963, 42(September):1382-1390.
3. Bosch L.J., Eernisse J.G., van Leeuwen A., Loeliger E.A., van Rood J.J. Treatment of thrombocytopenic patients with repeated platelet transfusions. Rev Belg Pathol Med Exp 1965, 31(April):139-145.
4. Bortin M.M., Bach F.H., van Bekkum D.W., Good R.A., van Rood J.J. 25th anniversary of the first successful allogeneic bone marrow transplants. Bone Marrow Transpl 1994, 14(August (2)):211-212.
5. Speck B., Zwaan F.E., van Rood J.J., Eernisse J.G. Allogeneic bone marrow transplantation in a patient with aplastic anaemia using a phenotypicall HLA-matched unrelated donor. Transplantation 1973, 16(1):24-28.
6. Vossen J.M., de Koning J., van Bekkum D.W., Dicke K.A., Eysvoogel V.P., Hijmans W., et al. Succesful treatment of an infant with severe combined immunodeficiency by transplantation of bone marrow cells from an uncle. Clin Exp Immunol 1973, 13:9-20.
7. Speck B., Dooren L.J., de Koning J., van Bekkum D.W., Eernisse J.G., Elkerbout F., et al. Clinical experience with bone marrow transplantation: failure and success. Transpl Proc 1971, 3(1):409-413.
8. van Rood J.J. Significance of leukocyte groups in transplantation serology. Bibl Haematol 1971, 37:53-69.
9. Brand A., van Leeuwen A., Eernisse J.G., van Rood J.J. Platelet transfusion therapy. Optimal donor selection with a combination of lymphocytotoxicity and platelet fluorescence test. Blood 1978, 51:78-88.
10. Eernisse J.G., Brand A. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components. Exp Hematol 1981, 9:74-83.
11. van Rood J.J. A proposal for international cooperation in organ transplantation: Eurotransplant. Histocompatibility testing 1967, Williams & Wilkins, Baltimore.
12. Lems S.P., Tamboer W.P., Capel P.J., Koene R.A. Effects of IgG and IgM alloantibodies in the enhancement of mouse skin allografts and the relation with their opsonizing capacity in vivo. J Immunol 1981, 127(August (2)):665-669.
13. van Rood J.J., van Leeuwen A., van den Tweel J.G., Blussé van Oud Alblas A., Keuning J.J., Eernisse J.G. Typing for the MLC determinants and its possible impact on Europdonor. Transpl Proc 1974, 6(December (4)):411-415.
14. van Rood J.J., van Leeuwen A., Keuning J.J., van Oud Alblas A.B. The serological recognition of the human MLC determinants using a modified cytotoxicity technique. Tissue Antigens 1975, 5(April (2)):73-79.
15. Goulmy E., Termijtelen A., Bradley B.A., van Rood J.J. Y-antigen killing by T cells of women is restricted by HLA. Nature 1977, 266(April (5602)):544-545.
16. Mutis T., Gillespie G., Schrama E., Falkenburg J.H., Moss P., Goulmy E. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med 1999, 5(July (7)):839-842.
17. den Haan J.M., Meadows L.M., Wang W., Pool J., Blokland E., Bishop T.L., et al. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 1998, 279(February (5353)):1054-1057.
18. Paul L.C., Claas F.H., van Es L.A., Kalff M.W., de Graeff J. Accelerated rejection of a renal allograft associated with pretransplantation antibodies directed against donor antigens on endothelium and monocytes. N Engl J Med 1979, 300(May (22)):1258-1260.
19. Joosten S.A., Sijpkens Y.W., van Ham V., Trouw L.A., van der Vlag J., van den Heuvel B., et al. Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy. Am J Transplant 2005, 5(February (2)):383-393.
20. Larhammar D., Hylgen-Nielsen J.J., Servenius B., Andersson G., Rask L., Peterson P.A. Exon-intron organization and complete nucleotide sequence of a major histocompatibility antigen DC beta gene. Proc Natl Acad Sci USA 1983, 80:7313-7317.
21. Rollini P., Mach B., Gorski J. Linkage map of three HLA-DR beta chain genes: evidence for a recent duplication event. Proc Natl Acad Sci USA 1985, 82:7197-7201.
22. Spies T., Sorrentino R., Boss J.M., Okada K., Strominger J.L. Structural organization of the DR subregion of the human major histocompatibility complex. Proc Natl Acad Sci USA 1985, 82:5165-5169.
23. Trowsdale J., Ragoussis J., Campbell R.D. Map of the human MHC. Immunol Today 1991, 12:443-446.
24. Shiina T., Tamiya G., Oka A., Takishima N., Yamagata T., Kikkawa E., et al. Molecular dynamics of MHC genesis unraveled by sequence analysis of the 1,796,938-bp HLA class I region. Proc Natl Acad Sci USA 1999, 96(November (23)):13282-13287.
25. Beck, et al. Complete sequence and gene map of a human major histocompatibility complex. Nature 1999, 401:921-923.
26. Olerup O., Zetterquist H. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992, 39:225-235.
27. Angelini G., de Preval C., Gorski J., Mach B. High resolution analysis of HLA-DR polymorphism by hybridization with sequence specific oligonucleotide probes. Proc Natl Acad Sci USA 1986, 83:4489-4493.
28. Santamaria P., Lindstrom A.L., Boyce-Jacino M.T., Myster S.H., Barbosa J.J., Faras A.J., et al. HLA class I sequence-based typing. Hum Immunol 1993, 37(May (1)):39-50.
29. Scheltinga S.A., Williams F., Van der Zwan A.W., Rozemuller E.H., Middleton D., Tilanus M.G.J. HLA-A towards a high resolution DNA typing. Tissue Antigens 1998, 51:549-552.
30. Voorter C.E., Palusci F., Tilanus M.G.J. Sequence-based typing of HLA: an improved group-specific full-length gene sequencing approach. Methods in molecular biology 2014, 101-114. Humana Press, New York. 2nd edn. M. Beksaç (Ed.).
31. Erlich H. HLA-DNA typing: past, present and future. Tissue Antigens 2012, 80:1-11.
32. Petersdorf E.W., Malkki M., Gooley T.A., Spellman S.R., Haagenson M.D., Horowitz M.M., et al. MHC-resident variation affect risks after unrelated donor hematopoietic cell transplantation. Sci Transl Med 2012, 4:144ra101.
33. Claas F.H., Gijbels Y., van der Velden-de Munck J., van Rood J.J. Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. Science 1988, 241(September (4874)):1815-1817.
34. Burlingham W.J., Grailer A.P., Heisey D.M., Claas F.H., Norman D., Mohanakumar T., et al. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med 1998, 339(December (23)):1657-1664.
35. van Rood J.J., Loberiza F.R., Zhang M.J., Oudshoorn M., Claas F., Cairo M.S., et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood 2002, 99(March (5)):1572-1577.
36. van Rood J.J., Stevens C.E., Smits J., Carrier C., Carpenter C., Scaradavou A. Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies. Proc Natl Acad Sci USA 2009, 106(November (47)):19952-19957.
37. van Rood J.J., Scaradavou A., Stevens C.E. Indirect evidence that maternal microchimerism in cord blood mediates a graft-versus-leukemia effect in cord blood transplantation. Proc Natl Acad Sci USA 2012, 109(February (7)):2509-2514.
38. Claas F.H., Rahmel A., Doxiadis I.I. Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program. Transplantation 2009, 88(August (4)):447-452.
39. de Klerk M., Witvliet M.D., Haase-Kromwijk B.J., Claas F.H., Weimar W. Hurdles, barriers, and successes of a national living donor kidney exchange program. Transplantation 2008, 86(December (12)):1749-1753.
40. Persijn G.G., Cohen B., Lansbergen Q., van Rood J.J. Retrospective and prospective studies on the effect of blood transfusions in renal transplantation in The Netherlands. Transplantation 1979, 28(November (5)):396-401.
41. Lagaaij E.L., Hennemann I.P., Ruigrok M., de Haan M.W., Persijn G.G., Termijtelen A., et al. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 1989, 321(September (11)):701-705.
42. van Twuyver E., Mooijaart R.J., ten Berge I.J., van der Horst A.R., Wilmink J.M., Kast W.M., et al. Pretransplantation blood transfusion revisited. N Engl J Med 1991, 325(October (17)):1210-1213.
43. Knulst A.C., Bril-Bazuin C., Tibbe G.J., Benner R. Improved survival from potentially lethal graft-vs.-host disease by donor pretreatment with a recipient-specific blood transfusion. I. Requirements for induction and specificity of the effect. Eur J Immunol 1992, 22(October (10)):2481-2486.
44. Bean M.A., Mickelson E., Yanagida J., Ishioka S., Brannen G.E., Hansen J.A. Suppressed antidonor MLC responses in renal transplant candidates conditioned with donor-specific transfusions that carry the recipient's noninherited maternal HLA haplotype. Transplantation 1990, 49(February (2)):382-386.
45. Leonard A.A., Jonker M., Lagaaij E.L. Complete withdrawal of immunosuppression in allograft recipients. A study in rhesus monkeys. Transplantation 1996, 61(June (11)):1648-1651.
46. Reinders M.E., de Fijter J.W., Roelofs H., Bajema I.M., de Vries D.K., Schaapherder A.F., et al. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl Med 2013, 2(February (2)):107-111.